Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by hmmmmmmmmon Feb 11, 2024 2:44pm
311 Views
Post# 35874612

 "Material News" in a nutshell?

 "Material News" in a nutshell?

Many here will remember the abrupt sell off in the days leading up to the Feb 4 2020 news release of the Baxter- Spectral partnership.  

 

And I am sure they’d remember how suspicious the sell down looked- it was hard to not see it as a group using inside info to kick down the share price, and color the news of the Baxter deal. (AB 80 anyone?)

 

Are we again on the verge of Baxter/ Spectral news? and will we see similar inside info games?

 

After years of Spectral publishing statements a la "At 90 patients Baxter will have access to raw data "

 

Spectral has now removed that language- now simply stating: "Baxter has the option to make the second milestone payment"

 

Does this mean Baxter had already accessed the Tigris data? would that be material- given the numerous, previous assertions to investors?

 

Would investors hear if that data had changed the Baxter/Spectral relationship- if say Baxter was now actively using their influence with Drs. and hospitals to increase Tigris enrollment?

 

If such changes have happened- when will Spectral management notify their shareholders? Or how long will insiders alone hold that information? Will we see the 2020 games by those inside play out again? 

 

Let’s see what next week brings…

<< Previous
Bullboard Posts
Next >>